Topiramate as treatment for hemifacial spasm.

Abstract

OBJECTIVE:

To report a patient with hemifacial spasm (HFS) which improved with topiramate.

CASE REPORT:

A 52-year-old woman diagnosed with migraine, who also had a right HFS, did experience a marked improvement of HFS after introduction of topiramate as prophylactic therapy for her migraine episodes. Topiramate withdrawal led to reappearance of HFS, which improved again after its reintroduction.

CONCLUSIONS:

Topiramate should be considered as a possible therapy for HFS.

• Authors: Hortensia Alonso-Navarro, Lluisa Rubio, Félix Javier Jiménez-Jiménez
• Journal: Clinical neuropharmacology (Clin Neuropharmacol) 2007 Sep-Oct Vol. 30 Issue 5 Pg. 308-9 ISSN: 0362-5664 [Print] United States
• PMID: 17909311 (Publication Type: Case Reports, Journal Article)

Chemical References

• Neuroprotective Agents
• Topiramate
• Fructose

Topics

• Female
• Fructose (analogs & derivatives, therapeutic use)
• Hemifacial Spasm (drug therapy)
• Humans
• Middle Aged
• Neuroprotective Agents (therapeutic use)
• Topiramate